Resumen

FLEITMAN-BRODER, Carlos. Periocular capillary hemangioma in 2018: natural course, indications for treatment and therapeutic options. Rev. mex. oftalmol [online]. 2019, vol.93, n.3, pp.159-165.  Epub 06-Jul-2021. ISSN 2604-1227.  https://doi.org/10.24875/rmoe.m19000065.

Capillary hemangiomas are one of the most common benign orbital and eyelid childhood tumors. Many of these tumors do not require treatment because they regress spontaneously without leaving sequelae; however, treatment is necessary in many cases, such as amblyogenic or eye-threatening lesions. Treatment of this kind of lesions has evolved from surgical excision to laser and steroids, all of them successful in different ways and with a range of side effects. In the last few years treatment has been revolutionized due to a casual finding made by Leaute-Labreze et al. Nowadays we use beta-blockers that have proved to be highly effective and with a much safer profile than previously used drugs. Several case reports have shown success by treating these lesions with topical beta-blockers. With this safer and more effective treatment, we can currently treat this lesions that in the past were just kept under observation, diminishing the cosmetic sequelae and the social stigma of patients having such lesions in their facial area.

Palabras llave : Eyelid neoplasms (therapy); Hemangioma capillary (therapy); Orbital neoplasms (therapy); Propranolol (therapeutic use); Facial neoplasms (therapy).

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )